As the president and CEO of COTA Healthcare, Sasu is working to solve a core problem in the industry: "how to use data to ...

The age of artificial intelligence (AI) has transformed our interactions, but threatens human dignity on a worldwide scale, ...

Recognized globally for over two decades of innovation, leadership, and contributions to software engineering, Rupenkumar ...

A new project by a team of researchers across the nation analyzes the ways in which digitized health data, artificial ...

AI-generated papers are on the rise, and concerns grow around authorship, AI plagiarism, and maintaining trust in ...

In this episode presented by IQVIA, BioSpace's head of insights Lori Ellis discusses the evolving role of local qualified persons for pharmacovigilance with ⁠Ana Pedro Jesuíno⁠, global head local QPPV ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

Companies that master basic data governance will be best positioned to extract true value from their information assets while minimizing costs and risks.

These capabilities illustrate the multifaceted promise of AI: speeding up scientific discovery, improving patient outcomes, ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...